A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

[1]  G. Chan,et al.  Longterm results of a prospective study of 225 femoral hernia repairs: indications for tissue and mesh repair. , 2008, Journal of the American College of Surgeons.

[2]  E. Lesaffre,et al.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin , 2006, Histopathology.

[3]  K. Chijiiwa,et al.  Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. , 2005, Journal of hepato-biliary-pancreatic surgery.

[4]  S. Thorgeirsson,et al.  Comparative functional genomics for identifying models of human cancer. , 2005, Carcinogenesis.

[5]  S. Thorgeirsson,et al.  Genetic profiling of human hepatocellular carcinoma. , 2005, Seminars in liver disease.

[6]  S. Thorgeirsson,et al.  Application of comparative functional genomics to identify best-fit mouse models to study human cancer , 2004, Nature Genetics.

[7]  S. Thorgeirsson,et al.  Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. , 2004, Gastroenterology.

[8]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[9]  S. Thorgeirsson,et al.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling , 2004, Hepatology.

[10]  S. Thorgeirsson,et al.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Zavadil,et al.  Gene expression pattern in hepatic stem/progenitor cells during rat fetal development using complementary DNA microarrays , 2004, Hepatology.

[12]  J. Bruix,et al.  Focus on hepatocellular carcinoma. , 2004, Cancer cell.

[13]  A. McClatchey,et al.  Ezrin...a metastatic detERMinant? , 2004, Cancer cell.

[14]  Javed Khan,et al.  Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators , 2004, Nature Medicine.

[15]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[16]  S. Jothy.  CD44 and its partners in metastasis , 2004, Clinical & Experimental Metastasis.

[17]  Hiroaki Kitano,et al.  Cancer robustness: Tumour tactics , 2003, Nature.

[18]  S. Thorgeirsson,et al.  Overview of recent experimental studies on liver stem cells. , 2003, Seminars in liver disease.

[19]  T. Roskams,et al.  Progenitor cells in diseased human liver. , 2003, Seminars in liver disease.

[20]  D. Shafritz,et al.  Hepatic stem cells and liver repopulation. , 2003, Seminars in liver disease.

[21]  S. Kubo,et al.  Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence , 2003, Cancer science.

[22]  R. Mansel,et al.  The role of the CD44/ezrin complex in cancer metastasis. , 2003, Critical reviews in oncology/hematology.

[23]  E. Wagner,et al.  Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.

[24]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[25]  Z. Werb,et al.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. , 2001, Trends in cell biology.

[26]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[27]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[28]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[29]  M. Magnuson,et al.  DNA excision in liver by an albumin‐Cre transgene occurs progressively with age , 2000, Genesis.

[30]  P. Andreasen,et al.  The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.

[31]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[32]  V. Desmet,et al.  The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. , 1999, Journal of hepatology.

[33]  C. Gouillat,et al.  Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study. , 1999, Journal of the American College of Surgeons.

[34]  J. Wands,et al.  The increasing incidence of hepatocellular carcinoma. , 1999, The New England journal of medicine.

[35]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[36]  J. Bruix,et al.  Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials , 1999, Hepatology.

[37]  A. Odén,et al.  The rising incidence of hepatocellular carcinoma. , 1999, The New England journal of medicine.

[38]  E. Van Cutsem,et al.  Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? , 2008, Liver.

[39]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[40]  J. Lau,et al.  Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. , 1996, The American journal of pathology.

[41]  R. Poulsom,et al.  Cell behavior in the acetylaminofluorene-treated regenerating rat liver. Light and electron microscopic observations. , 1994, The American journal of pathology.

[42]  E. Wagner,et al.  c-Jun is essential for normal mouse development and hepatogenesis , 1993, Nature.

[43]  R. Palmiter,et al.  An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. , 1987, Genes & development.